Challenges to Safety in the Global Drug Supply Chain
A special issue of Challenges (ISSN 2078-1547).
Deadline for manuscript submissions: closed (1 October 2013) | Viewed by 269
Special Issue Editors
2. San Diego Center for Patient Safety, University of California, San Diego School of Medicine, 200 West Arbor Drive, San Diego, CA 92103, USA
3. Institute of Health Law Studies, California Western School of Law, 350 Cedar Street, San Diego, CA 92101, USA
4. Joint Program on Health Policy & Law, University of California, San Diego, California Western School of Law, San Diego, CA 92037, USA
Interests: patient safety; global health; health policy; global drug supply; online pharmacies; e-Health
2. San Diego Center for Patient Safety, University of California, San Diego School of Medicine, 200 West Arbor Drive, San Diego, CA 92103, USA
3. Institute of Health Law Studies, California Western School of Law, 350 Cedar Street, San Diego, CA 92101, USA
4. Joint Program on Health Policy & Law, University of California, San Diego, California Western School of Law, San Diego, CA 92037, USA
Interests: global governance; global health; health policy; global drug supply; online pharmacies; e-Health; e-Marketing
Special Issue Information
Dear Colleagues,
Pharmaceuticals are critical health delivery system instruments within medicine that lead to improved quality and quantity of life. Yet the convergence of global sourcing, facilitated international trade, and emerging worldwide criminal networks have led to tremendous challenges to ensure safety of the global drug supply chain. Recent penetrations of the legitimate supply chain by counterfeit and illicit forms in developed and developing countries, encompassing lifestyle and lifesaving medications, including generic and branded forms, spanning oral and injectable medications, and treating communicable and noncommunicable diseases illustrate this expanding global patient safety threat is not limited to any geopolitical unit or area. Further, illicit sourcing, marketing, and sales through avenues such as the Internet and business-to-business forums have vastly increased this reach and potential harm from the criminal activities associated with counterfeit and illicit medication sales.
Recognizing this, international efforts have been made to address the challenges to a safe, robust supply chain, including those centered about WHO, the UN, Interpol, and private sector stakeholders. However, at present, strategies to address the vulnerabilities of the global drug supply chain have been limited and ineffective, suffering from technical, exclusionary, and competency-based weaknesses across forums and stakeholders. Consequently, new research, conceptions, collaborations, theoretical frameworks, global governance, and health policy approaches are urgently needed to reflect the rapidly increasing presence of illicit actors exploiting vulnerabilities in global drug supply chain.
This Special Issue will focus on new strategies, methodologies, and thinking to address the deep patient safety risks associated with global drug supply chain vulnerabilities. Importantly, these papers will provide insights using inter- and cross-disciplinary efforts to tackle this complex issue, reflecting upon root causes and informed approaches. Through these insights, global health policy can emerge and facilitate promotion of patient safety in the drug supply chain worldwide while bringing the criminals exploiting these vulnerabilities to justice.
Prof. Dr. Bryan A. Liang
Prof. Timothy K. Mackey
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Challenges is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- global health
- drug supply safety
- counterfeit drugs
- organized crime
- online pharmacies
- patient safety
- global health policy
- global governance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
